Nutritional Growth Solutions was founded by paediatric doctors at the Schneider Children’s Medical Centre of Israel after more than 20 years of research into the link between nutrition and child growth development.

The research found that while 80% of height is determined by genetics, 20% can be influenced by specific combinations of micro and macro nutrients taken at certain developmental ages in children between three years and puberty.

The patented formula is sold globally under various brands and including a shake formula and nutrition bar through pharmacies and health food stores, distributors and online through the Healthy Heights® website, T-Mall Global (China) and Amazon in five countries – China, United States, Italy, Canada, Israel and in India through Unilever under licence.

  • Mr David Fenlon
    Mr David Fenlon Non Executive Chairman

    David Fenlon has over 30 years’ experience in retail and consumer goods across Europe, Australasia and North America. He was the Managing Director & CEO of leading beauty and wellness business BWX Limited (ASX: BWX), and was previously Managing Director – Australia & NZ for Blackmores Limited (ASX: BKL). In addition, Mr Fenlon is currently a Non-executive Director of Quest for Life Foundation, an Australian not-for-profit organisation dedicated to supporting people through personal traumas.

    • Mr Stephen Turner
      Mr Stephen Turner Chief Executive Officer

      Stephen Turner joined the Company in 2021 as the President of the North American division of the Company.

      As President, Mr. Turner oversees and leads the US-based sales, marketing, product development, and operations teams. This team is responsible for the overall sales growth of the Company, product and market expansion in the US and global markets.

      With over 25 years of experience in product research and development, marketing, and sales, Mr. Turner has spearheaded several successful products and ventures within the consumer supplements and pharmaceutical industries, both domestically and internationally.

      • Prof Raanan Shamir
        Prof Raanan Shamir Executive Director & Chief Medical Officer

        Raanan Shamir is Professor of Pediatrics at the Tel Aviv University, and Chairman of the Institute of Gastroenterology, Nutrition and Liver Diseases at Schneider.

        Prof. Shamir received his Medical Doctor (MD) degree at the Hebrew University in Jerusalem. In the early 90s, he was a fellow at the Division of Pediatric Gastroenterology and Nutrition at The Children’s Hospital of Philadelphia.

        Prof. Shamir has published approximately 400 original papers, reviews and comments, book chapters and guidelines. His current research areas include pediatric nutrition, nutrition and growth, celiac disease, inflammatory bowel disease and childhood hyperlipidemia.

        Prof. Shamir is a co-founder of the Company.

        • Peter Osborne
          Peter Osborne Non-Executive Director

          Peter Osborne is a highly credentialed leader and business advisor with a unique combination of executive level commercial and government diplomatic experience in Asia, particularly in China. Peter has substantial hands-on experience in entering and developing business in new markets, building teams across multiple geographies, driving sales and profit growth, and operating in remote and culturally complex locations.

          Since early 2020, Peter has provided strategic advice on China and Asia market entry to over 30 companies (publicly listed and private) from Australia, USA, Europe, Japan and Korea in the food, healthcare, skincare; cosmetics, fashion, and FMCG space driving successful business expansion into new channels and markets at both a tactical/operational and strategic level.

          Peter served as Australia’s most senior trade diplomat as Australian Senior Trade Commissioner in Beijing, Shanghai, Hong Kong and Taiwan over a 23-year career with the Australian government developing successful market entry, investment, promotional and marketing strategies for foreign and domestic products and services in Asia, with a particular focus on Greater China.

          • Guy Khavia
            Guy Khavia External Director

            Guy Khavia is an experienced CFO with a track record of delivering financial, strategic, and operational leadership across both public and private sectors. With a wealth of experience as a senior consultant in accounting and auditing, Guy has consistently demonstrated expertise in management, finance, and legal functions. His proficiency extends to working closely with multiple stock exchanges and driving successful initiatives for leading global corporations, guiding them through capital raising, M&A, and exit strategies.
            Notably, Guy’s recent role as CFO & Director at Dotz Nano Limited underscored his exceptional leadership. His commitment to compliance, combined with his expertise in financial reporting and strategic collaboration, has solidified his reputation as an instrumental financial executive.
            His previous role at Amplifon as a Regional CFO highlights his ability to lead global organizations through complex financial landscapes. From overseeing monthly closings to guiding M&A endeavors, Guy has consistently exhibited a deft touch in managing financial teams, implementing ERP systems, and driving cost-effective transformations.

            • Rachel Hirsh
              Rachel Hirsh External Director

              Rachel Hirsh has two decades of global and multinational experience as a seasoned senior leader. She has held pivotal positions such as Co-owner and COO/CFO at Meditex Group Ltd, CFO & Operations Manager at Qualitest Group, and CFO at Strauss Group. Rachel’s vast expertise extends to providing strategic consulting and mentorship to both established corporations and startups, underscoring her unwavering commitment to nurturing success.
              Furthermore, Rachel has assumed roles as External Director and Finance Committee Chairperson at Fresh Market Ltd. and Flying Spark Ltd., signifying her instrumental involvement in steering organizational strategies. Notably, Rachel’s contributions as CFO at Qualitest Group prove to be of paramount importance, as she plays a significant role in shaping the company’s strategic vision and driving the implementation of operational strategies.
              Rachel’s extensive experience and versatile skill set position her as a transformative leader capable of adeptly navigating complexities and championing operational excellence.

              • Prof Moshe Phillip
                Prof Moshe Phillip Chief Scientific Officer

                Moshe Phillip graduated from Ben-Gurion University, Beer-Sheba, Israel, in 1983.

                He has been the Director of the Institute for Endocrinology and Diabetes, the National Center for Childhood Diabetes at Schneider since 1997, and serves as Vice Dean for research and development as well as a Chair of the Irene and Nicholas Marsh Fund for Endocrinology and Diabetes at the Sackler Faculty of Medicine, Tel-Aviv University.

                Prof. Phillip is active in both clinical and basic research focusing on childhood diabetes, growth, nutrition, and obesity and specifically on diabetes technologies and the interaction between nutrition and growth.

                Prof. Phillip has more than 270 publications, the ATTD Yearbook, N&G yearbook, as well as chapters in other textbooks.

                Prof. Phillip is a co-founder of the Company.

                • Dr Michal Yackobovitch-Gavan
                  Dr Michal Yackobovitch-Gavan Director of Clinical Studies

                  Dietitian and researcher at the Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Dr. Yackobovitch-Gavan studies the interplay between childhood nutrition and growth.

                  She is also the Coordinator of the University Center for the Study of Nutrition, Growth and Development at Schneider Children’s Medical Center of Israel.